Trump Admin's 'Tuskegee 2.0' Hepatitis B Vaccine Study on Black Infants

Controversial Hepatitis B Vaccine Study

• 🎯 A $1.6 million study funded by the Trump administration's Department of Health and Human Services (HHS) is reportedly planned for newborns in Guinea-Bissau.
• 💡 The study aims to conduct a randomized controlled trial on 14,000 infants to assess the effects of the neonatal Hepatitis B vaccine birth dose on mortality, morbidity, and long-term development.
• ⚠️ Half of the infants will receive the vaccine birth dose, while the other half will not, to observe potential negative health effects.

Ethical Concerns and Scrutiny

• 🔬 The study design has drawn comparisons to the historical Tuskegee syphilis study, which targeted Black men.
• 🧐 The researchers involved have faced prior scrutiny for questionable research practices and poor scientific conduct, according to a peer review analysis.
• 🚫 Despite ethical concerns and the host country's stated cancellation due to study design issues, HHS officials reportedly insisted the trial would proceed.

RFK Jr.'s Role and Policy Shift

• 🧠 The proposal emerged as Robert F. Kennedy Jr. was considering a policy shift away from universally recommending the Hepatitis B birth dose, a measure credited with virtually eliminating mother-to-infant transmission.
• 🗣️ An HHS assistant secretary stated the trial would proceed as planned, even as the host nation expressed reservations about the study's design and the potential impact on their sovereignty and parental decision-making.

International Reaction and Opposition

• 🌍 The Africa CDC, an organization separate from the US CDC, engaged in a public relations campaign regarding the research.
• ⚖️ Critics argue that such human experimentation is unethical and treats infants as if they are subhuman, lacking dignity or the right to health.
• 📢 The host country's government has indicated the trial has been cancelled due to ethical concerns regarding the study design, though US CDC officials maintain it will proceed.